Login
$CRVS
$10.81 +$0.21 (1.98%) After hours

$CRVS SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Arcara Jeffrey, Chief Business Officer

Bought 3,000 shares ($34.4K) · Bought 497 shares ($5.52K) · Bought 1,003 shares ($10.6K)

10 Nov 2026 SCHEDULE 13G
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on track

07 Aug 2026 SCHEDULE 13G
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on track

27 Jul 2026 SCHEDULE 13G/A
22 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

15 Jun 2026 Form 4: Moore David Scott, Director

Bought 21,700 shares ($250K) · Granted 15,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: Clark Ian T, Director

Granted 15,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: Grais Linda, Director

Granted 15,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: Thompson Peter A., Director

Granted 15,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: van den Broek Richard, Director

Granted 15,000 Stock Option (Right to Buy)

12 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On June 11, 2026, Corvus Pharmaceuticals, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Only stockholders of record at the close of business on April 16, 2026, the record date for the Annual Me...

20 May 2026 Form 4: Miller Richard A Md, Director

Bought 6,932 shares ($83.5K)

15 May 2026 SCHEDULE 13G/A
15 May 2026 SCHEDULE 13G
14 May 2026 8-K: Regulation FD Disclosure; Other Events

Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting

07 May 2026 FORM S-8

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support